Strong physician confidence, widespread regulatory approvals, and high patient adoption all helped to establish its leadership
doi: 10.1016/j.numecd.2019.07.012
Similar content being viewed by others Introduction Obesity and type 2 diabetes (T2D) are chronic conditions of public health concern and rising global prevalence [1,2,3]
(2023, February 8)
Were hopeful for the future, but were talking years down the track, and because the public and practitioners know about these medications, theyre the ones who are advocating for the Government to look into this to make access available for those who need [these medications] most, which are often the people who can least afford it. Dr South added that if Wegovy secures a listing on the PBS as a weight-loss treatment, GPs can be prepared for more patients asking about the drug
Key takeaways Weight loss potential: While some studies suggest that tirzepatide may be more effective for weight loss, more research is necessary to confirm this